Asset Management
Compare Stocks
5 / 10Stock Comparison
WT vs GROW vs DHIL vs MORN vs ARES
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management - Global
Asset Management
Financial - Data & Stock Exchanges
Asset Management
WT vs GROW vs DHIL vs MORN vs ARES — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Asset Management | Asset Management - Global | Asset Management | Financial - Data & Stock Exchanges | Asset Management |
| Market Cap | $2.65B | $35M | $473M | $6.77B | $40.44B |
| Revenue (TTM) | $494M | $8M | $158M | $2.45B | $6.47B |
| Net Income (TTM) | $109M | $98K | $49M | $403M | $527M |
| Gross Margin | 72.1% | 41.7% | 96.0% | 61.0% | 74.8% |
| Operating Margin | 35.3% | -35.3% | 38.4% | 21.5% | 27.2% |
| Forward P/E | 17.3x | — | 9.5x | 15.0x | 20.2x |
| Total Debt | $957M | $83K | $6.40B | $1.41B | $14.91B |
| Cash & Equiv. | $312M | $25M | $42M | $475M | $1.50B |
WT vs GROW vs DHIL vs MORN vs ARES — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| WisdomTree, Inc. (WT) | 100 | 626.4 | +526.4% |
| U.S. Global Investo… (GROW) | 100 | 125.4 | +25.4% |
| Diamond Hill Invest… (DHIL) | 100 | 164.0 | +64.0% |
| Morningstar, Inc. (MORN) | 100 | 116.0 | +16.0% |
| Ares Management Cor… (ARES) | 100 | 326.1 | +226.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: WT vs GROW vs DHIL vs MORN vs ARES
Each card shows where this stock fits in a portfolio — not just who wins on paper.
WT carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 15.4%, EPS growth 127.3%
- Efficiency ratio 0.4% vs GROW's 0.8% (lower = leaner)
- +103.1% vs MORN's -39.6%
- Efficiency ratio 0.4% vs GROW's 0.8%
GROW is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.71, Low D/E 0.2%, current ratio 20.87x
DHIL ranks third and is worth considering specifically for valuation efficiency and defensive.
- PEG 1.14 vs MORN's 1.32
- Beta 0.57, yield 5.7%, current ratio 75115.85x
- Lower P/E (9.5x vs 20.2x), PEG 1.14 vs 1.15
MORN is the clearest fit if your priority is income & stability.
- Dividend streak 12 yrs, beta 0.52, yield 1.0%
- Beta 0.52 vs ARES's 1.62, lower leverage
ARES is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 9.3% 10Y total return vs WT's 92.6%
- 66.6% NII/revenue growth vs GROW's -23.1%
- 6.6% yield, 7-year raise streak, vs MORN's 1.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 66.6% NII/revenue growth vs GROW's -23.1% | |
| Value | Lower P/E (9.5x vs 20.2x), PEG 1.14 vs 1.15 | |
| Quality / Margins | Efficiency ratio 0.4% vs GROW's 0.8% (lower = leaner) | |
| Stability / Safety | Beta 0.52 vs ARES's 1.62, lower leverage | |
| Dividends | 6.6% yield, 7-year raise streak, vs MORN's 1.0% | |
| Momentum (1Y) | +103.1% vs MORN's -39.6% | |
| Efficiency (ROA) | Efficiency ratio 0.4% vs GROW's 0.8% |
WT vs GROW vs DHIL vs MORN vs ARES — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
WT vs GROW vs DHIL vs MORN vs ARES — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
DHIL leads in 1 of 6 categories
MORN leads 1 • GROW leads 1 • WT leads 1 • ARES leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
DHIL leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
ARES is the larger business by revenue, generating $6.5B annually — 765.5x GROW's $8M. DHIL is the more profitable business, keeping 30.9% of every revenue dollar as net income compared to GROW's -4.0%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $494M | $8M | $158M | $2.4B | $6.5B |
| EBITDAEarnings before interest/tax | $179M | -$2M | $62M | $763M | $1.8B |
| Net IncomeAfter-tax profit | $109M | $98,000 | $49M | $403M | $527M |
| Free Cash FlowCash after capex | $149M | -$235,000 | $44.5B | $437M | $1.5B |
| Gross MarginGross profit ÷ Revenue | +72.1% | +41.7% | +96.0% | +61.0% | +74.8% |
| Operating MarginEBIT ÷ Revenue | +35.3% | -35.3% | +38.4% | +21.5% | +27.2% |
| Net MarginNet income ÷ Revenue | +22.1% | -4.0% | +30.9% | +15.3% | +8.2% |
| FCF MarginFCF ÷ Revenue | +30.2% | -9.8% | -57.4% | +18.1% | +23.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +55.6% | — | +25.3% | +50.0% | -80.9% |
Valuation Metrics
MORN leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 9.8x trailing earnings, DHIL trades at a 84% valuation discount to ARES's 62.8x P/E. Adjusting for growth (PEG ratio), DHIL offers better value at 1.18x vs ARES's 3.56x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.7B | $35M | $473M | $6.8B | $40.4B |
| Enterprise ValueMkt cap + debt − cash | $3.3B | $10M | $6.8B | $7.7B | $53.9B |
| Trailing P/EPrice ÷ TTM EPS | 24.97x | -104.80x | 9.77x | 20.06x | 62.83x |
| Forward P/EPrice ÷ next-FY EPS est. | 17.30x | — | 9.48x | 14.95x | 20.23x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.18x | 1.77x | 3.56x |
| EV / EBITDAEnterprise value multiple | 18.53x | — | 110.39x | 10.75x | 26.88x |
| Price / SalesMarket cap ÷ Revenue | 5.37x | 4.14x | 3.00x | 2.77x | 6.25x |
| Price / BookPrice ÷ Book value/share | 6.56x | 0.77x | 2.70x | 6.14x | 3.08x |
| Price / FCFMarket cap ÷ FCF | 17.77x | — | — | 15.29x | 26.19x |
Profitability & Efficiency
GROW leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
MORN delivers a 30.0% return on equity — every $100 of shareholder capital generates $30 in annual profit, vs $0 for GROW. GROW carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to DHIL's 36.26x. On the Piotroski fundamental quality scale (0–9), ARES scores 8/9 vs GROW's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +26.5% | +0.2% | +27.0% | +30.0% | +6.2% |
| ROA (TTM)Return on assets | +8.6% | +0.2% | +19.5% | +10.9% | +1.9% |
| ROICReturn on invested capital | +11.4% | -4.7% | +1.3% | +15.3% | +6.1% |
| ROCEReturn on capital employed | +16.2% | -6.2% | +26.0% | +20.6% | +7.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 2 | 6 | 6 | 8 |
| Debt / EquityFinancial leverage | 2.31x | 0.00x | 36.26x | 1.15x | 1.71x |
| Net DebtTotal debt minus cash | $645M | -$24M | $6.4B | $933M | $13.4B |
| Cash & Equiv.Liquid assets | $312M | $25M | $42M | $475M | $1.5B |
| Total DebtShort + long-term debt | $957M | $83,000 | $6.4B | $1.4B | $14.9B |
| Interest CoverageEBIT ÷ Interest expense | 5.54x | 600.00x | — | 12.40x | 2.68x |
Total Returns (Dividends Reinvested)
WT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WT five years ago would be worth $27,380 today (with dividends reinvested), compared to $4,143 for GROW. Over the past 12 months, WT leads with a +103.1% total return vs MORN's -39.6%. The 3-year compound annual growth rate (CAGR) favors WT at 43.0% vs MORN's -0.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +50.0% | +7.7% | +2.8% | -15.0% | -25.1% |
| 1-Year ReturnPast 12 months | +103.1% | +27.8% | +33.8% | -39.6% | -21.1% |
| 3-Year ReturnCumulative with dividends | +192.3% | +3.3% | +22.4% | -2.2% | +64.7% |
| 5-Year ReturnCumulative with dividends | +173.8% | -58.6% | +28.3% | -29.1% | +160.2% |
| 10-Year ReturnCumulative with dividends | +92.6% | +67.4% | +55.4% | +131.7% | +929.6% |
| CAGR (3Y)Annualised 3-year return | +43.0% | +1.1% | +7.0% | -0.7% | +18.1% |
Risk & Volatility
Evenly matched — DHIL and MORN each lead in 1 of 2 comparable metrics.
Risk & Volatility
MORN is the less volatile stock with a 0.52 beta — it tends to amplify market swings less than ARES's 1.62 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DHIL currently trades 100.0% from its 52-week high vs MORN's 56.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.44x | 0.71x | 0.57x | 0.52x | 1.62x |
| 52-Week HighHighest price in past year | $19.29 | $3.65 | $175.03 | $316.71 | $195.26 |
| 52-Week LowLowest price in past year | $9.10 | $2.10 | $114.11 | $149.08 | $95.80 |
| % of 52W HighCurrent price vs 52-week peak | +97.1% | +71.8% | +100.0% | +56.2% | +63.1% |
| RSI (14)Momentum oscillator 0–100 | 67.2 | 46.5 | 70.5 | 42.1 | 63.2 |
| Avg Volume (50D)Average daily shares traded | 3.0M | 25K | 23K | 509K | 3.7M |
Analyst Outlook
Evenly matched — MORN and ARES each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: WT as "Buy", MORN as "Hold", ARES as "Buy". Consensus price targets imply 44.0% upside for ARES (target: $177) vs -0.2% for WT (target: $19). For income investors, ARES offers the higher dividend yield at 6.56% vs WT's 0.64%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — | — | Hold | Buy |
| Price TargetConsensus 12-month target | $18.70 | — | — | $236.50 | $177.38 |
| # AnalystsCovering analysts | 17 | — | — | 6 | 22 |
| Dividend YieldAnnual dividend ÷ price | +0.6% | +3.5% | +5.7% | +1.0% | +6.6% |
| Dividend StreakConsecutive years of raises | 0 | 1 | 1 | 12 | 7 |
| Dividend / ShareAnnual DPS | $0.12 | $0.09 | $9.98 | $1.82 | $8.08 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.9% | +5.6% | +3.6% | +11.6% | 0.0% |
DHIL leads in 1 of 6 categories (Income & Cash Flow). MORN leads in 1 (Valuation Metrics). 2 tied.
WT vs GROW vs DHIL vs MORN vs ARES: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is WT or GROW or DHIL or MORN or ARES a better buy right now?
For growth investors, Ares Management Corporation (ARES) is the stronger pick with 66.
6% revenue growth year-over-year, versus -23. 1% for U. S. Global Investors, Inc. (GROW). Diamond Hill Investment Group, Inc. (DHIL) offers the better valuation at 9. 8x trailing P/E (9. 5x forward), making it the more compelling value choice. Analysts rate WisdomTree, Inc. (WT) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — WT or GROW or DHIL or MORN or ARES?
On trailing P/E, Diamond Hill Investment Group, Inc.
(DHIL) is the cheapest at 9. 8x versus Ares Management Corporation at 62. 8x. On forward P/E, Diamond Hill Investment Group, Inc. is actually cheaper at 9. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Diamond Hill Investment Group, Inc. wins at 1. 14x versus Morningstar, Inc. 's 1. 32x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — WT or GROW or DHIL or MORN or ARES?
Over the past 5 years, WisdomTree, Inc.
(WT) delivered a total return of +173. 8%, compared to -58. 6% for U. S. Global Investors, Inc. (GROW). Over 10 years, the gap is even starker: ARES returned +929. 6% versus DHIL's +55. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — WT or GROW or DHIL or MORN or ARES?
By beta (market sensitivity over 5 years), Morningstar, Inc.
(MORN) is the lower-risk stock at 0. 52β versus Ares Management Corporation's 1. 62β — meaning ARES is approximately 211% more volatile than MORN relative to the S&P 500. On balance sheet safety, U. S. Global Investors, Inc. (GROW) carries a lower debt/equity ratio of 0% versus 36% for Diamond Hill Investment Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — WT or GROW or DHIL or MORN or ARES?
By revenue growth (latest reported year), Ares Management Corporation (ARES) is pulling ahead at 66.
6% versus -23. 1% for U. S. Global Investors, Inc. (GROW). On earnings-per-share growth, the picture is similar: WisdomTree, Inc. grew EPS 127. 3% year-over-year, compared to -126. 6% for U. S. Global Investors, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — WT or GROW or DHIL or MORN or ARES?
Diamond Hill Investment Group, Inc.
(DHIL) is the more profitable company, earning 30. 9% net margin versus -4. 0% for U. S. Global Investors, Inc. — meaning it keeps 30. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DHIL leads at 38. 4% versus -35. 3% for GROW. At the gross margin level — before operating expenses — DHIL leads at 96. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is WT or GROW or DHIL or MORN or ARES more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Diamond Hill Investment Group, Inc. (DHIL) is the more undervalued stock at a PEG of 1. 14x versus Morningstar, Inc. 's 1. 32x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Diamond Hill Investment Group, Inc. (DHIL) trades at 9. 5x forward P/E versus 20. 2x for Ares Management Corporation — 10. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ARES: 44. 0% to $177. 38.
08Which pays a better dividend — WT or GROW or DHIL or MORN or ARES?
All stocks in this comparison pay dividends.
Ares Management Corporation (ARES) offers the highest yield at 6. 6%, versus 0. 6% for WisdomTree, Inc. (WT).
09Is WT or GROW or DHIL or MORN or ARES better for a retirement portfolio?
For long-horizon retirement investors, Morningstar, Inc.
(MORN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 52), 1. 0% yield, +131. 7% 10Y return). Both have compounded well over 10 years (MORN: +131. 7%, WT: +92. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between WT and GROW and DHIL and MORN and ARES?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: WT is a small-cap high-growth stock; GROW is a small-cap income-oriented stock; DHIL is a small-cap deep-value stock; MORN is a small-cap quality compounder stock; ARES is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.